Community-reported Cytarabine side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Cytarabine Side Effect Episode
Have You dealt with a Cytarabine side effect? Share your experience
Review Cytarabine Safety Reports submitted to FDA
Total Cytarabine reports: 295.Cytarabine FDA safety alerts: No.
Reported deaths: 53 Reported hospitalizations: 189.
Take Cytarabine Side Effects Survey, Discuss Cytarabine with others
FDA Reported Cytarabine Side Effects: febrile neutropenia, haemoglobin decreased, platelet count decreased, blood culture positive, disease progression, hypotension, sepsis, white blood cell count decreased, diarrhoea haemorrhagic, pyrexia, haematocrit decreased.
Cytarabine Usage.
If you have questions about Cytarabine, you can ask a Health Expert or Ask Patient Community about Cytarabine.
< Previous Showing 201-295 of 295
Cytarabine Side Effects Report #5469457-1Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Sept 25, 2007. Male patient, weighting 272.3 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, haemodialysis, renal failure. CYTARABINE dosage: 1645 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient recovered.
Cytarabine Side Effects Report #5469757-5
CYTARABINE problem was reported by a Pharmacist from UNITED STATES on Sept 26, 2007. Male patient, weighting 155.4 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, lip swelling, palmar-plantar erythrodysaesthesia syndrome. CYTARABINE dosage: 5400 MG X1 IV DRIP. Patient recovered.
Cytarabine Side Effects Report #5470329-7
Health Professional from UNITED KINGDOM reported CYTARABINE problem on Sept 14, 2007. Female patient, 42 years of age, was diagnosed with t-cell chronic lymphocytic leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: herpes zoster, hyperkeratosis. CYTARABINE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CAMPATH, CARMUSTINE, MELPHALAN, ACYCLOVIR. Patient recovered.
Cytarabine Side Effects Report #5470330-3
CYTARABINE problem was reported by a Health Professional from UNITED STATES on Sept 17, 2007. Male patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: disease progression, disseminated intravascular coagulation, febrile bone marrow aplasia, febrile neutropenia, hepatic candidiasis, hepatic lesion, liver abscess, sepsis. CYTARABINE dosage: 20 MG/M2 PER_CYCLE IV. Patient was hospitalized. Patient died on 01/02/2006.
Cytarabine Side Effects Report #5472377-X
Physician from UNITED STATES reported CYTARABINE problem on Sept 17, 2007. Female patient, 54 years of age, was diagnosed with mantle cell lymphoma and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome. CYTARABINE dosage: unknown. During the same period patient was treated with METHOTREXATE, VINCRISTINE, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBUCIN, DEXAMETHASONE, MESNA. Patient died.
Cytarabine Side Effects Report #5472378-1
CYTARABINE problem was reported by a Physician from UNITED STATES on Sept 17, 2007. Female patient, 61 years of age, was diagnosed with mantle cell lymphoma and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome. CYTARABINE dosage: unknown. During the same period patient was treated with METHOTREXATE, VINCRISTINE, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, DEXAMETHASONE, MESNA. Patient died.
Cytarabine Side Effects Report #5472379-3
Physician from UNITED STATES reported CYTARABINE problem on Sept 17, 2007. Female patient, 79 years of age, was diagnosed with mantle cell lymphoma and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome. CYTARABINE dosage: unknown. During the same period patient was treated with METHOTREXATE, VINCRISTINE, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, DEXAMETHASONE, MESNA. Patient died.
Cytarabine Side Effects Report #5472552-4
CYTARABINE problem was reported by a Health Professional from UNITED STATES on Sept 20, 2007. Female patient, 82 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, decreased appetite, diarrhoea, disease progression, fatigue, hypotension, lethargy, malaise, skin turgor decreased. CYTARABINE dosage: 20 MG/M2 PER_CYCLE SC. During the same period patient was treated with GLYCOPYRROLATE, MAXOLON, PHOSPHATE, ATORVASTATIN CALCIUM, PANADEINE CO, ALLOPURINOL, AMIODARONE HYDROCHLORIDE, BETAGAN. Patient was hospitalized. Patient died on 02/23/2007.
Cytarabine Side Effects Report #5473142-X
Physician from AUSTRIA reported CYTARABINE problem on Sept 19, 2007. Female patient, 56 years of age, was diagnosed with metastases to meninges and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: hydrocephalus, leukoencephalopathy, metastases to central nervous system. CYTARABINE dosage: 50 MG; QM; INTH. During the same period patient was treated with TEMOZOLOMIDE, CARBOPLATIN. Patient recovered.
Cytarabine Side Effects Report #5474515-1
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 28, 2007. Male patient, weighting 178.6 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, mucosal inflammation, pancytopenia. CYTARABINE dosage: 32000 MG. During the same period patient was treated with ETOPOSIDE, DAPSONE, GLUCOPHAGE, KLONOPIN, PAPCID, POTASSIUM CHLORIDE, RISPERDAL, ATIVAN. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5406240-7
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Aug 02, 2007. Female patient, weighting 52.91 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, aspergillosis, blood calcium decreased, blood fibrinogen increased, bone marrow failure, bronchopulmonary aspergillosis, fluid overload, fungal infection, haematuria. CYTARABINE dosage: 7030 MG. During the same period patient was treated with MITOXANTRONE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5406242-0
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2007. Male patient, weighting 187.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: headache, nausea, vomiting. CYTARABINE dosage: 3900 MG. During the same period patient was treated with DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, LEUCOVORIN CALCIUM, MESNA, METHOTREXATE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5407143-4
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Aug 03, 2007. Female patient, weighting 179.0 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: cerumen impaction, dehydration, diplopia, gait disturbance, gaze palsy, hallucination, lumbar puncture abnormal, nausea, nuclear magnetic resonance imaging brain abnormal. CYTARABINE dosage: 1428 MG. During the same period patient was treated with DAUNORUBICIN, CELEXA. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5408275-7
CYTARABINE problem was reported by a Consumer or non-health professional from NETHERLANDS on July 16, 2007. Male patient, 65 years of age, weighting 209.4 lb, was diagnosed with acute myeloid leukaemia, epilepsy and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: encephalopathy. CYTARABINE dosage: 200 MG/M2. During the same period patient was treated with KEPPRA, AVASTIN, FRISIUM, FUNGIZONE, METOPROLOL SUCCINAAT, KONAKION MM, HALDOL, FLUCONAZOL. Patient recovered.
Cytarabine Side Effects Report #5409564-2
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Aug 07, 2007. Female patient, weighting 137.3 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, blood pressure diastolic decreased, culture stool positive, diarrhoea, enterococcal infection, febrile neutropenia, skin disorder. CYTARABINE dosage: 3200 MG. During the same period patient was treated with ETOPOSIDE, RITUXIMAB. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5419187-7
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2007. Female patient, weighting 196.2 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, continuous haemodiafiltration, hypotension, multi-organ failure, pneumonia, renal tubular necrosis, respiratory distress, respiratory failure, sepsis. CYTARABINE dosage: 1013.55 MG. During the same period patient was treated with DAUNORUBICIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5419188-9
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Aug 15, 2007. Male patient, weighting 189.6 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: ascites, clostridium difficile colitis, gastrointestinal necrosis, proctocolitis, pseudomembranous colitis, small intestinal obstruction, urine output decreased. CYTARABINE dosage: 33600 MG. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5422309-5
CYTARABINE problem was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Aug 08, 2007. Male patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, empyema, haematocrit decreased, haemoglobin decreased, malignant neoplasm progression, pleural effusion, pneumonia klebsiella, refusal of treatment by patient. CYTARABINE dosage: 20 MG/M2 DAILY SC. During the same period patient was treated with ACETAMINOPHEN, FENTANYL, MAGNESIUM SULPHATE, DIGOXIN. Patient was hospitalized. Patient died on 11/16/2006.
Cytarabine Side Effects Report #5424701-1
Pharmacist from UNITED STATES reported CYTARABINE problem on Aug 22, 2007. Female patient, 28 years of age, weighting 108.5 lb, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: odynophagia, oedema peripheral, pain in extremity, palmar-plantar erythrodysaesthesia syndrome. CYTARABINE dosage: 1490MG IV QD X 5D. During the same period patient was treated with CLOFARABINE, CEFEPIME, FLAGYL, CASPOFUNGIN, COMBIPATCH, NYSTATIN, COLACE, INSULIN. Patient recovered.
Cytarabine Side Effects Report #5426051-6
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2007. Male patient, weighting 169.8 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: chills, haemoptysis, infusion site erythema, infusion site reaction, pyrexia, wound secretion. CYTARABINE dosage: 29600 MG. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5426059-0
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Aug 24, 2007. Male patient, weighting 179.0 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver function test abnormal, stem cell transplant, transaminases increased. CYTARABINE dosage: 700 MG. During the same period patient was treated with DAUNORUBICIN. Patient recovered.
Cytarabine Side Effects Report #5429296-4
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 27, 2007. Female patient, weighting 196.2 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, blood creatinine increased, blood urea increased, febrile neutropenia, haemodialysis, hypotension, multi-organ failure, pneumonia, renal tubular necrosis. CYTARABINE dosage: 1013.55 MG. During the same period patient was treated with DAUNORUBICIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5430445-2
Health Professional from POLAND reported CYTARABINE problem on Aug 14, 2007. Male patient was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: anaemia, bronchopneumonia, disease progression, gastroenteritis, neutropenia, thrombocytopenia. CYTARABINE dosage: 20 MG/M2 PER_CYCLE SC. During the same period patient was treated with ETAMSILATE, TRANEXAMIC ACID, ATORVASTATIN, PERINDOPRIL ERBUMINE, OMEPRAZOLE, CODEINE PHOSPHATE, AMINOPHYLLINE, AMIKACIN. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5435765-3
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2007. Male patient, weighting 224.9 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, diarrhoea, febrile neutropenia, haemoglobin decreased, hypoxia, renal failure, streptococcal infection, tachycardia, tachypnoea. CYTARABINE dosage: 6.5 MG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5441901-5
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Aug 30, 2007. Female patient, weighting 196.2 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, febrile neutropenia, haemodialysis, hypotension, multi-organ failure, pneumonia, renal tubular necrosis, respiratory failure, sepsis. CYTARABINE dosage: 1013.55 MG. During the same period patient was treated with DAUNORUBICIN, ETOPOSIDE. Patient was hospitalized. Patient died on 08/28/2007.
Cytarabine Side Effects Report #5443319-8
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 31, 2007. Female patient, weighting 180.3 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, c-reactive protein increased, cardiac arrest, cardiovascular disorder, cholestasis, enterococcal sepsis, hyperbilirubinaemia, hyperglycaemia, hypertriglyceridaemia. CYTARABINE dosage: 14870 MG. During the same period patient was treated with MITOXANTRONE, AMPHOTERICIN B. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5451851-6
Health Professional from UNITED STATES reported CYTARABINE problem on Nov 20, 2006. Male patient, 69 years of age, weighting 244.9 lb, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: bacteraemia, candida sepsis. CYTARABINE dosage: 3435 MG BID; IV. During the same period patient was treated with LISINOPRIL, TESTOSTERONE, METOPROLOL, FELODIPINE, SIMVASTATIN, ZETIA. Patient died on 02/16/2006.
Cytarabine Side Effects Report #5451854-1
CYTARABINE problem was reported by a Health Professional from UNITED STATES on Jan 24, 2007. Male patient, 75 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, pyrexia. CYTARABINE dosage: 20 MG/M2 DAILY; SC. During the same period patient was treated with LIPITOR, FLOMAX, ALBUTEROL, ADVAIR DISKUS, CITRUCEL. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5451855-3
Health Professional from UNITED STATES reported CYTARABINE problem on Feb 27, 2007. Female patient, 59 years of age, weighting 157.4 lb, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: neurotoxicity. CYTARABINE dosage: 2745 MG BID; IV. Patient died on 02/15/2007.
Cytarabine Side Effects Report #5451856-5
CYTARABINE problem was reported by a Health Professional from UNITED STATES on Feb 27, 2007. Female patient, 59 years of age, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: bacteraemia. CYTARABINE dosage: unknown. Patient recovered.
Cytarabine Side Effects Report #5451858-9
Health Professional from UNITED STATES reported CYTARABINE problem on Mar 05, 2007. Male patient, 81 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. CYTARABINE dosage: 20 MG/M2 PER_CYCLE; SC. During the same period patient was treated with TERAZOSIN HYDROCHLORIDE, ARANESP, RED BLOOD CELLS, ENOFER, TOPROL, ASPIRIN, VASOTEC, NITROSTAT. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5299690-3
CYTARABINE problem was reported by a Consumer or non-health professional from FRANCE on Mar 16, 2007. Male patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: disease progression, disseminated intravascular coagulation, sepsis. CYTARABINE dosage: 20 MG/M2 PER_CYCLE IV. Patient died.
Cytarabine Side Effects Report #5378341-3
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 02, 2007. Male patient, weighting 187.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: arthropod bite, erythema, febrile neutropenia, fungal infection, local swelling. CYTARABINE dosage: 36000 MG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5378382-6
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 02, 2007. Female patient, weighting 130.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: anorexia, biopsy bone marrow abnormal, blast cells present, cholelithiasis, colitis, febrile neutropenia, malnutrition, oral intake reduced. CYTARABINE dosage: 1162 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient recovered.
Cytarabine Side Effects Report #5379790-X
Physician from AUSTRALIA reported CYTARABINE problem on June 21, 2007. Male patient, child 6 years of age, was diagnosed with t-cell type acute leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: trichostasis spinulosa. CYTARABINE dosage: unknown. During the same period patient was treated with DAUNORUBICIN, METHOTREXATE, VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISONE, ASPARAGINASE, THIOGUANINE, MERCAPTOPURINE. Patient recovered.
Cytarabine Side Effects Report #5383840-4
CYTARABINE problem was reported by a Physician from UNITED STATES on June 26, 2007. Male patient, 56 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome. CYTARABINE dosage: 500MG/M2 IV/EVERY 12 HRS FOR 6. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5385278-2
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 09, 2007. Male patient, weighting 198.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased. CYTARABINE dosage: 4120 MG. During the same period patient was treated with ETOPOSIDE, ACYCLOVIR, ATENOLOL, ATIVAN, BACTRIM, COLACE, DULCOLAX, FLUCONAZOLE. Patient recovered.
Cytarabine Side Effects Report #5386400-4
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2007. Male patient, weighting 198.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, platelet count decreased. CYTARABINE dosage: 4120 MG. During the same period patient was treated with ETOPOSIDE, ACYCLOVIR, ATENOLOL, ATIVAN, BACTRIM, COLACE, DULCOLAX, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5387666-7
Pharmacist from UNITED STATES reported CYTARABINE problem on July 12, 2007. Female patient, 59 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, cardiomyopathy, leukopenia, pyrexia. CYTARABINE dosage: unknown. During the same period patient was treated with LASIX, DOCUSATE, GABAPENTIN, HEPARIN, INSULIN, ISOSORBIDE DINITRATE, LISINOPRIL. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5390180-6
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Male patient, weighting 233.7 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, thrombocytopenia. CYTARABINE dosage: 1540 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5390182-X
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 16, 2007. Male patient, weighting 162.7 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: diverticular perforation, pancytopenia, pelvic abscess, post procedural complication, sepsis, small intestinal obstruction. CYTARABINE dosage: 1344 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5390183-1
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Female patient, weighting 52.91 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain, abdominal pain upper, aspergillosis, blood calcium decreased, blood fibrinogen increased, breath sounds absent, bronchopulmonary aspergillosis, flank pain. CYTARABINE dosage: 7030 MG. During the same period patient was treated with MITOXANTRONE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5390898-5
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 10, 2007. Male patient, 64 years of age, weighting 182.3 lb, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. CYTARABINE dosage: unknown. During the same period patient was treated with MITOXANTRONE, ETOPOSIDE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5392035-X
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 18, 2007. Female patient, weighting 183.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: caecitis, neutropenic colitis, sinus tachycardia. CYTARABINE dosage: 31360 MG. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5392147-0
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 18, 2007. Female patient, weighting 167.3 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: epistaxis, mouth haemorrhage, platelet count abnormal, skin haemorrhage. CYTARABINE dosage: 16650 MG. Patient recovered.
Cytarabine Side Effects Report #5394811-6
CYTARABINE problem was reported by a Health Professional from UNITED STATES on July 11, 2007. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, catheter sepsis, disease progression, escherichia infection, gastrointestinal erosion, haemorrhage, septic shock. CYTARABINE dosage: 20 MG/M2 PER_CYCLE SC. During the same period patient was treated with CIPROFLOXACIN, BISEPTOL, ORUNGAL, FORTUM, VANCOMYCIN, METROGYL. Patient died on 10/26/2006.
Cytarabine Side Effects Report #5394923-7
Health Professional from UNITED STATES reported CYTARABINE problem on July 12, 2007. Male patient, 84 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: blood bicarbonate decreased, blood culture positive, blood ph decreased, febrile neutropenia, haemoglobin decreased, pco2 decreased, platelet count decreased, po2 increased, red blood cell count decreased. CYTARABINE dosage: 20 MG/M2 QD SC. During the same period patient was treated with TAPAZOLE, OMEPRAZOLE, SIMVASTATIN, TOCOPHEROL, VITAMIN B CAP, LINUM USITATISSIMUM, VITALUX. Patient died on 04/05/2007.
Cytarabine Side Effects Report #5397657-8
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 23, 2007. Female patient, weighting 141.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: chromaturia, haemoglobin decreased, hypokalaemia, neutropenia, oral pain, pharyngolaryngeal pain, pyrexia, white blood cell count decreased. CYTARABINE dosage: 3000 MG. During the same period patient was treated with ETOPOSIDE, IFOSFAMIDE, LEUCOVORIN CALCIUM, MESNA, METHOTREXATE, RITUXIMAB, VINCRISTINE SULPHATE, NEUPOGEN. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5397794-8
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 23, 2007. Male patient, weighting 192.5 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: acute hepatic failure, dehydration, electrolyte imbalance, hepatic encephalopathy, nausea, vomiting, weight decreased. CYTARABINE dosage: 70 MG. During the same period patient was treated with ELSPAR. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5398925-6
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2007. Female patient, weighting 127.0 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood culture positive, computerised tomogram abnormal, fluid overload, neutropenia, pleural effusion, tachycardia, transfusion-related acute lung injury. CYTARABINE dosage: 1127 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5398975-X
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 24, 2007. Male patient, weighting 238.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. CYTARABINE dosage: unknown. During the same period patient was treated with ETOPOSIDE, RITUXIMAB. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5399146-3
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2007. Female patient, weighting 127.0 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, alanine aminotransferase increased, alpha haemolytic streptococcal infection, aspartate aminotransferase increased, blood creatinine increased, blood culture positive, bradycardia, cerebral haemorrhage, dialysis. CYTARABINE dosage: 1127 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5400053-8
Pharmacist from UNITED STATES reported CYTARABINE problem on July 26, 2007. Male patient, 52 years of age, weighting 105.8 lb, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: chills, erysipelas, erythema, facial pain, febrile neutropenia, gastrooesophageal reflux disease, rash, swelling, thrombocytopenia. CYTARABINE dosage: 2400 MG Q12H DAY 1,3,5 IV. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5400098-8
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2007. Female patient, weighting 200.6 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. CYTARABINE dosage: unknown. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5400128-3
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 26, 2007. Male patient, weighting 257.9 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: decreased appetite, facial pain, feeling abnormal, gingival pain, mucosal inflammation. CYTARABINE dosage: 41760 MG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5400185-4
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 27, 2007. Male patient, weighting 198.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, platelet count decreased. CYTARABINE dosage: 4120 MG. During the same period patient was treated with ETOPOSIDE, ACYCLOVIR, ATENOLOL, ATIVAN, BACTRIM, COLACE, DULCOLAX, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5400459-7
Physician from TURKEY reported CYTARABINE problem on July 16, 2007. Male patient, 53 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: dizziness, sinus bradycardia. CYTARABINE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CISPLATIN, GRANISETRON. Patient recovered.
Cytarabine Side Effects Report #5401209-0
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Male patient, 80 years of age, weighting 289.0 lb, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, atelectasis, bacterial infection, blood culture positive, blood fibrinogen increased, chronic obstructive pulmonary disease, diarrhoea, enterococcal infection, gastrointestinal haemorrhage. CYTARABINE dosage: 1000 MG/M2 QD X 5 IV. During the same period patient was treated with ALBUTEROL, SPIRIVA, NABUMETONE, NOVOLIN, HYDROMORPHONE. Patient was hospitalized. Patient died on 07/13/2007.
Cytarabine Side Effects Report #5402052-9
Health Professional from UNITED STATES reported CYTARABINE problem on July 17, 2007. Female patient, child 7 years of age, was diagnosed with acute leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: aphasia, cerebrovascular spasm, encephalopathy, hallucination, visual, incontinence, muscular weakness, screaming. CYTARABINE dosage: 70 MG/INTRATHECAL. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5403919-8
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2007. Male patient, weighting 272.3 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, haemodialysis, renal failure. CYTARABINE dosage: 1645 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient recovered.
Cytarabine Side Effects Report #5404695-5
Health Professional from UNITED KINGDOM reported CYTARABINE problem on July 17, 2007. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, sepsis. CYTARABINE dosage: 20 MG BID SC. During the same period patient was treated with ZARNESTRA. Patient died.
Cytarabine Side Effects Report #5404696-7
CYTARABINE problem was reported by a Health Professional from UNITED KINGDOM on July 17, 2007. Male patient, 75 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: lower respiratory tract infection fungal, pneumonia. CYTARABINE dosage: 20 MG BID SC. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient died.
Cytarabine Side Effects Report #5404697-9
Health Professional from UNITED KINGDOM reported CYTARABINE problem on July 17, 2007. Male patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, febrile neutropenia, malignant neoplasm progression, productive cough, respiratory tract infection fungal. CYTARABINE dosage: 20 MG BID SC. During the same period patient was treated with ZARNESTRA. Patient died on 06/14/2007.
Cytarabine Side Effects Report #5299690-3
CYTARABINE problem was reported by a Consumer or non-health professional from FRANCE on Mar 16, 2007. Male patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: disease progression, disseminated intravascular coagulation, sepsis. CYTARABINE dosage: 20 MG/M2 PER_CYCLE IV. Patient died.
Cytarabine Side Effects Report #5378341-3
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 02, 2007. Male patient, weighting 187.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: arthropod bite, erythema, febrile neutropenia, fungal infection, local swelling. CYTARABINE dosage: 36000 MG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5378382-6
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 02, 2007. Female patient, weighting 130.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: anorexia, biopsy bone marrow abnormal, blast cells present, cholelithiasis, colitis, febrile neutropenia, malnutrition, oral intake reduced. CYTARABINE dosage: 1162 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient recovered.
Cytarabine Side Effects Report #5379790-X
Physician from AUSTRALIA reported CYTARABINE problem on June 21, 2007. Male patient, child 6 years of age, was diagnosed with t-cell type acute leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: trichostasis spinulosa. CYTARABINE dosage: unknown. During the same period patient was treated with DAUNORUBICIN, METHOTREXATE, VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISONE, ASPARAGINASE, THIOGUANINE, MERCAPTOPURINE. Patient recovered.
Cytarabine Side Effects Report #5383840-4
CYTARABINE problem was reported by a Physician from UNITED STATES on June 26, 2007. Male patient, 56 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome. CYTARABINE dosage: 500MG/M2 IV/EVERY 12 HRS FOR 6. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5385278-2
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 09, 2007. Male patient, weighting 198.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased. CYTARABINE dosage: 4120 MG. During the same period patient was treated with ETOPOSIDE, ACYCLOVIR, ATENOLOL, ATIVAN, BACTRIM, COLACE, DULCOLAX, FLUCONAZOLE. Patient recovered.
Cytarabine Side Effects Report #5386400-4
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2007. Male patient, weighting 198.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, platelet count decreased. CYTARABINE dosage: 4120 MG. During the same period patient was treated with ETOPOSIDE, ACYCLOVIR, ATENOLOL, ATIVAN, BACTRIM, COLACE, DULCOLAX, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5387666-7
Pharmacist from UNITED STATES reported CYTARABINE problem on July 12, 2007. Female patient, 59 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, cardiomyopathy, leukopenia, pyrexia. CYTARABINE dosage: unknown. During the same period patient was treated with LASIX, DOCUSATE, GABAPENTIN, HEPARIN, INSULIN, ISOSORBIDE DINITRATE, LISINOPRIL. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5390180-6
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Male patient, weighting 233.7 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, thrombocytopenia. CYTARABINE dosage: 1540 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5390182-X
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 16, 2007. Male patient, weighting 162.7 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: diverticular perforation, pancytopenia, pelvic abscess, post procedural complication, sepsis, small intestinal obstruction. CYTARABINE dosage: 1344 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5390183-1
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Female patient, weighting 52.91 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain, abdominal pain upper, aspergillosis, blood calcium decreased, blood fibrinogen increased, breath sounds absent, bronchopulmonary aspergillosis, flank pain. CYTARABINE dosage: 7030 MG. During the same period patient was treated with MITOXANTRONE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5390898-5
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 10, 2007. Male patient, 64 years of age, weighting 182.3 lb, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. CYTARABINE dosage: unknown. During the same period patient was treated with MITOXANTRONE, ETOPOSIDE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5392035-X
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 18, 2007. Female patient, weighting 183.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: caecitis, neutropenic colitis, sinus tachycardia. CYTARABINE dosage: 31360 MG. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5392147-0
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 18, 2007. Female patient, weighting 167.3 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: epistaxis, mouth haemorrhage, platelet count abnormal, skin haemorrhage. CYTARABINE dosage: 16650 MG. Patient recovered.
Cytarabine Side Effects Report #5394811-6
CYTARABINE problem was reported by a Health Professional from UNITED STATES on July 11, 2007. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, catheter sepsis, disease progression, escherichia infection, gastrointestinal erosion, haemorrhage, septic shock. CYTARABINE dosage: 20 MG/M2 PER_CYCLE SC. During the same period patient was treated with CIPROFLOXACIN, BISEPTOL, ORUNGAL, FORTUM, VANCOMYCIN, METROGYL. Patient died on 10/26/2006.
Cytarabine Side Effects Report #5394923-7
Health Professional from UNITED STATES reported CYTARABINE problem on July 12, 2007. Male patient, 84 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: blood bicarbonate decreased, blood culture positive, blood ph decreased, febrile neutropenia, haemoglobin decreased, pco2 decreased, platelet count decreased, po2 increased, red blood cell count decreased. CYTARABINE dosage: 20 MG/M2 QD SC. During the same period patient was treated with TAPAZOLE, OMEPRAZOLE, SIMVASTATIN, TOCOPHEROL, VITAMIN B CAP, LINUM USITATISSIMUM, VITALUX. Patient died on 04/05/2007.
Cytarabine Side Effects Report #5397657-8
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 23, 2007. Female patient, weighting 141.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: chromaturia, haemoglobin decreased, hypokalaemia, neutropenia, oral pain, pharyngolaryngeal pain, pyrexia, white blood cell count decreased. CYTARABINE dosage: 3000 MG. During the same period patient was treated with ETOPOSIDE, IFOSFAMIDE, LEUCOVORIN CALCIUM, MESNA, METHOTREXATE, RITUXIMAB, VINCRISTINE SULPHATE, NEUPOGEN. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5397794-8
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 23, 2007. Male patient, weighting 192.5 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: acute hepatic failure, dehydration, electrolyte imbalance, hepatic encephalopathy, nausea, vomiting, weight decreased. CYTARABINE dosage: 70 MG. During the same period patient was treated with ELSPAR. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5398925-6
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2007. Female patient, weighting 127.0 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood culture positive, computerised tomogram abnormal, fluid overload, neutropenia, pleural effusion, tachycardia, transfusion-related acute lung injury. CYTARABINE dosage: 1127 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5398975-X
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 24, 2007. Male patient, weighting 238.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. CYTARABINE dosage: unknown. During the same period patient was treated with ETOPOSIDE, RITUXIMAB. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5399146-3
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2007. Female patient, weighting 127.0 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: